T2 Biosystems COO Acquires $165,000 in Stock (TTOO)
T2 Biosystems (NASDAQ:TTOO) COO Sarah O. Kalil bought 15,000 shares of T2 Biosystems stock on the open market in a transaction that occurred on Tuesday, August 12th. The shares were purchased at an average price of $11.00 per share, with a total value of $165,000.00. Following the completion of the transaction, the chief operating officer now directly owns 15,000 shares of the company’s stock, valued at approximately $165,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
T2 Biosystems (NASDAQ:TTOO) traded up 3.10% during mid-day trading on Thursday, hitting $17.29. The stock had a trading volume of 94,303 shares. T2 Biosystems has a one year low of $13.40 and a one year high of $17.24. The stock’s 50-day moving average is $14. and its 200-day moving average is $14.. The company’s market cap is $25.2 million.
T2 Biosystems, Inc is an in vitro diagnostics company. The Company that has developed a technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies.
Receive News & Ratings for T2 Biosystems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.